Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma
Status:
Recruiting
Trial end date:
2026-09-27
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether pembrolizumab given after standard ablative
Radiotherapy is a safe treatment that causes few or mild side effects in people with advanced
Adrenocortical Carcinoma.